-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Sana Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
- Sana Biotechnology, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$49.4M, a 57.5% increase year-over-year.
- Sana Biotechnology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$253M, a 31.3% increase year-over-year.
- Sana Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$293M, a 7.55% decline from 2022.
- Sana Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$273M, a 23.6% increase from 2021.
- Sana Biotechnology, Inc. annual Operating Income (Loss) for 2021 was -$357M, a 24.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)